Tema Heart & Health ETF (HRTS)
NasdaqGM: HRTS
· Prix en temps réel · USD
38.84
+1.01 (2.67%)
À la clôture : Aug 18, 2026, 3:25 PM
Tema Heart & Health ETF (HRTS) ETF Price, Holdings & Analysis
2.67% (1D)
| Bid | 26.28 |
| Capitalisation boursière | n/a |
| AUM | 54.27M |
| NAV | 37.28 |
| Bêta | n / A |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 26.41 |
| Parts en circulation | n / A |
| Date de création | Nov 20, 2023 |
| Ask | 47.47 |
| Volume | 3,128 |
| Moy. Volume (20D) | 5,819 |
| Ouverture | 38.61 |
| Clôture précédente | 37.83 |
| Fourchette du jour | 38.56 - 38.87 |
| Intervalle de 52 semaines | 29.02 - 38.87 |
| Positions | n / A |
| Ratio de frais | 0.75% |
À propos de HRTS
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Classe d’actifs Equity
Symbole boursier HRTS
Date de création Nov 20, 2023
Fournisseur Tema Etfs
Site web Page d’accueil du fonds
Échange NasdaqGM
10 principaux titres 48.89% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Eli Lilly And Co | LLY | 11.32% |
| Unitedhealth Group I... | UNH | 5.50% |
| Novo Nordisk As Clas... | NOVO-B.CO | 5.12% |
| Thermo Fisher Scient... | TMO | 4.54% |
| Roche Holding Ag Adr | RHHBY | 4.18% |
| Merck & Co Inc | MRK | 4.16% |
| Johnson & Johnson | JNJ | 3.86% |
| Astrazeneca PLC | AZN.L | 3.46% |
| Revolution Medicines... | RVMD | 3.44% |
| Novartis Ag Register... | NOVN.SW | 3.31% |
Dividendes Rendement du dividende 2.43%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Dec 10, 2025 | $0.4730 | n / A |
| Dec 11, 2024 | $0.4690 | n / A |
